Dr. Laura Rife, M.D

NPI: 1932214798
Total Payments
$1,980
2024 Payments
$139.75
Companies
29
Transactions
110
Medicare Patients
234
Medicare Billing
$21,262

Payment Breakdown by Category

Food & Beverage$1,895 (95.7%)
Education$85.00 (4.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,895 109 95.7%
Education $85.00 1 4.3%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $223.34 13 $0 (2021)
Amgen Inc. $182.92 11 $0 (2019)
PFIZER INC. $182.33 15 $0 (2019)
Novo Nordisk Inc $180.13 6 $0 (2024)
Astellas Pharma US Inc $165.50 5 $0 (2018)
GlaxoSmithKline, LLC. $152.88 7 $0 (2018)
PORTOLA PHARMACEUTICALS, LLC $136.81 1 $0 (2020)
Sunovion Pharmaceuticals Inc. $90.47 5 $0 (2018)
Novartis Pharmaceuticals Corporation $84.54 6 $0 (2019)
Shire North American Group Inc $76.96 6 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $139.75 2 Novo Nordisk Inc ($119.92)
2021 $83.04 1 AstraZeneca Pharmaceuticals LP ($83.04)
2020 $136.81 1 PORTOLA PHARMACEUTICALS, LLC ($136.81)
2019 $532.88 34 Amgen Inc. ($146.16)
2018 $694.63 46 Astellas Pharma US Inc ($142.56)
2017 $393.18 26 GlaxoSmithKline, LLC. ($131.05)

All Payment Transactions

110 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
11/07/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $119.92 General
04/27/2024 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $19.83 General
Category: ANTI-INFECTIVE
05/18/2021 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $83.04 General
Category: Respiratory
03/13/2020 PORTOLA PHARMACEUTICALS, LLC ANDEXXA (Biological) Food and Beverage In-kind items and services $136.81 General
Category: HEMATOLOGY/NEUROLOGY
10/02/2019 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $90.24 General
Category: Bone Health
09/19/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $11.40 General
Category: Hypertriglyceridemia
09/12/2019 Allergan Inc. LINZESS (Drug) Food and Beverage In-kind items and services $16.23 General
Category: GASTROENTEROLOGY
09/05/2019 PFIZER INC. PREVNAR - 13 (Biological), TRUMENBA Food and Beverage In-kind items and services $13.90 General
Category: VACCINES
09/05/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.03 General
Category: GASTROENTEROLOGY
08/27/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.34 General
Category: GASTROENTEROLOGY
08/26/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $11.10 General
Category: Diabetes
08/22/2019 Lilly USA, LLC TRULICITY (Drug), JARDIANCE Food and Beverage In-kind items and services $11.07 General
Category: Diabetes
08/21/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $9.52 General
Category: Neuroscience
08/16/2019 Allergan Inc. LINZESS (Drug) Food and Beverage In-kind items and services $22.73 General
Category: GASTROENTEROLOGY
08/14/2019 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $4.32 General
Category: Bone Health
08/12/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.00 General
Category: CARDIOVASCULAR
07/31/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $9.69 General
Category: Neuroscience
07/24/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $11.81 General
Category: Hypertriglyceridemia
07/16/2019 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.51 General
Category: Cardiovascular and Metabolism
07/10/2019 Neos Therapeutics, LP Adzenys XR-ODT (Drug), Cotempla XR-ODT Food and Beverage In-kind items and services $20.21 General
Category: ADHD
07/01/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.11 General
Category: CARDIOVASCULAR
06/25/2019 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $12.74 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
06/24/2019 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT Food and Beverage In-kind items and services $13.79 General
Category: RESPIRATORY
05/22/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $11.00 General
Category: Neuroscience
05/01/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.64 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 1 16 16 $3,040 $1,397
2021 2 120 123 $20,826 $11,606
2020 2 98 104 $18,176 $8,260
Total Patients
234
Total Services
243
Medicare Billing
$21,262
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 16 16 $3,040 $1,397 45.9%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 68 70 $13,300 $7,653 57.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 52 53 $7,526 $3,953 52.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 66 71 $13,490 $6,216 46.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 32 33 $4,686 $2,043 43.6%

About Dr. Laura Rife, M.D

Dr. Laura Rife, M.D is a Family Medicine healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932214798.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Rife, M.D has received a total of $1,980 in payments from pharmaceutical and medical device companies, with $139.75 received in 2024. These payments were reported across 110 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,895).

As a Medicare-enrolled provider, Rife has provided services to 234 Medicare beneficiaries, totaling 243 services with total Medicare billing of $21,262. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Shelbyville, IN
  • Active Since 08/20/2006
  • Last Updated 03/07/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1932214798

Products in Payments

  • ANDEXXA (Biological) $136.81
  • FARXIGA (Drug) $117.16
  • EVENITY (Biological) $100.12
  • BEXSERO (Biological) $99.78
  • CHANTIX (Drug) $87.33
  • ENTRESTO (Drug) $84.54
  • BREZTRI (Drug) $83.04
  • Utibron (Drug) $75.90
  • PREVNAR - 13 (Biological) $73.72
  • MYRBETRIQ (Drug) $57.56
  • Adzenys XR-ODT (Drug) $52.31
  • MYDAYIS (Drug) $49.46
  • XARELTO (Drug) $48.71
  • ANORO (Drug) $42.31
  • Aimovig (Biological) $40.47
  • Vascepa (Drug) $39.96
  • XIFAXAN (Drug) $39.66
  • LINZESS (Drug) $38.96
  • Prolia (Biological) $30.14
  • ELIQUIS (Drug) $27.63

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Shelbyville